Oramed Pharmaceuticals
ORMP
ORMP
46 hedge funds and large institutions have $19.1M invested in Oramed Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Holders
46
Holding in Top 10
2
Calls
$145K
Puts
–
Top Buyers
| 1 | +$288K | |
| 2 | +$222K | |
| 3 | +$64.4K | |
| 4 |
BlackRock
New York
|
+$63.8K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$63.1K |
Top Sellers
| 1 | -$191K | |
| 2 | -$150K | |
| 3 | -$114K | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$85K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$51.2K |
